Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8229059 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
This regimen did improve the survival of PCNSL patients but also caused substantial toxicity. The improvement in survival is less than that reported with high-dose methotrexate-based therapies.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Nadia N. M.D., Brian Patrick M.D., Karla V. Ph.D., Judith Rich Ph.D., Xiomara W. Carrero, Paul J. M.D., Bernd W. M.D., Paul D. M.D., Thomas M. M.D., Joseph P. M.D., Mark R. M.D., Roland B. M.D., Roscoe F. M.D., Harry E. M.D., Tom R. M.D.,